MRVI: Maravai LifeSciences Holdings, Inc. Class A Common Stock Company Profile & Statistics

Maravai LifeSciences Holdings, Inc. Class A Common Stock Profile

About

Maravai LifeSciences Holdings Inc. is a life sciences company providing products for the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company offer products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, protein labeling and detection to biopharmaceutical, vaccine, diagnostics and cell and gene therapy companies. Maravai LifeSciences Holdings Inc. is based in SAN DIEGO, Calif.

Info & Links

CEO

William E. Martin, III

Headquarters

10770 WATERIDGE CIRCLE SUITE 200
SAN DIEGO, CA 92121, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

570

Maravai LifeSciences Holdings, Inc. Class A Common Stock Statistics

Valuation Measures

Market Capitalization²

480.61M

Enterprise Value

560.26M

Enterprise Value/EBITDA(ttm)

-7.26

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

4.56

Price to Book(mrq)

2.03

Price to Cash(ytd)

5.55

Profitability

Gross Margin(ttm)

20.19%

Operating Margin(ttm)

-58.46%

Profit Margin(ttm)

-63.66%

Return on Equity(ttm)

-22.42%

Return on Invested Capital(ttm)

-26.22%

Return on Assets(ttm)

-12.11%

Income Statement

Revenue(ttm)

192.44M

Revenue Per Share(ttm)

0.75

Gross Profit(ttm)

40.54M

EBITDA(ttm)³

-77.20M

Net Income Available to Common(ttm)

-121.00M

Diluted EPS(ttm)

-0.84

Share Statistics

Beta (5Y Monthly)

0.32

52-Week Change

-38.75%

S&P 500 52-Week Change

15.66%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

255.71M

Dividend Yield

0.00%

Float⁴

250.31M

% Held by Insiders

2.11%

% Held by Institutions

50.25%

Balance Sheet

Total Cash(mrq)

243.57M

Total Cash Per Share(mrq)

0.95

Total Debt(mrq)

323.23M

Total Debt/Equity(mrq)

74.85%

Current Ratio(mrq)

5.29%

Quick Ratio(mrq)

4.56%

Book Value Per Share(mrq)

1.69

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.24

Free Cash Flow(ytd)

-45.84M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

MRVI

Maravai LifeSciences Holdings, Inc. Class A Common Stock